CLINICAL TRIALS PROFILE FOR CLEMIZOLE
✉ Email this page to a colleague
Clinical Trials for Clemizole
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00945880 ↗ | Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive | Completed | Eiger BioPharmaceuticals | Phase 1 | The purpose of this study is to test the hypothesis that clemizole hydrochloride is safe and well tolerated when administered to subjects who are infected with hepatitis C virus and have not yet received treatment. This study will also examine how the virus and body respond to clemizole hydrochloride. |
| NCT04069689 ↗ | Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects. | Completed | Epygenix | Phase 1 | This is a placebo-controlled, double-blind, 2-period study in 3 sequential groups of 8 healthy subjects each. The safety and pharmacokinetics of escalating single and multiple oral doses of EPX-100 will be assessed in fasting healthy subjects and following a high-fat meal. |
| NCT04462770 ↗ | EPX-100 (Clemizole Hydrochloride) as Add-on Therapy to Control Convulsive Seizures in Patients With Dravet Syndrome | Recruiting | GreenLight Clinical PTY LTD | Phase 2 | The purpose of this study is to compare the efficacy of EPX-100 against placebo as adjunctive therapy in 60 patients with Dravet Syndrome. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Clemizole
Condition Name
Clinical Trial Locations for Clemizole
Trials by Country
Clinical Trial Progress for Clemizole
Clinical Trial Phase
Clinical Trial Sponsors for Clemizole
Sponsor Name
